Literature DB >> 24097426

Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Heinrich Taegtmeyer1, Christophe Beauloye, Romain Harmancey, Louis Hue.   

Abstract

Reversing impaired insulin sensitivity has been suggested as treatment for heart failure. However, recent clinical evidence suggests the opposite. Here we present a line of reasoning in support of the hypothesis that insulin resistance protects the heart from the consequences of fuel overload in the dysregulated metabolic state of obesity and diabetes. We discuss pathways of myocardial fuel toxicity, as well as several layers of defense against fuel overload. Our reassessment of the literature suggests that in the heart, insulin-sensitizing agents result in an elimination of some of the defenses, leading to cytotoxic damage. In contrast, a normalization of fuel supply should either prevent or reverse the process. Taken together, we offer a new perspective on insulin resistance of the heart.

Entities:  

Keywords:  insulin resistance; metabolism; obesity

Mesh:

Substances:

Year:  2013        PMID: 24097426      PMCID: PMC3882545          DOI: 10.1152/ajpheart.00854.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.

Authors:  J D McGarry; G P Mannaerts; D W Foster
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus.

Authors:  Muthayyah Srinivasan; Pilar Herrero; Janet B McGill; Jasper Bennik; Bastiaan Heere; Donna Lesniak; Victor G Davila-Roman; Robert J Gropler
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

4.  Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

Authors:  G Paternostro; P G Camici; A A Lammerstma; N Marinho; R R Baliga; J S Kooner; G K Radda; E Ferrannini
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.

Authors:  M E Griffin; M J Marcucci; G W Cline; K Bell; N Barucci; D Lee; L J Goodyear; E W Kraegen; M F White; G I Shulman
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

6.  A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.

Authors:  Brian N Finck; Carlos Bernal-Mizrachi; Dong Ho Han; Trey Coleman; Nandakumar Sambandam; Lori L LaRiviere; John O Holloszy; Clay F Semenkovich; Daniel P Kelly
Journal:  Cell Metab       Date:  2005-02       Impact factor: 27.287

7.  Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

Authors:  Silvio E Inzucchi; Frederick A Masoudi; Yongfei Wang; Mikhail Kosiborod; Joanne M Foody; John F Setaro; Edward P Havranek; Harlan M Krumholz
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

8.  Insulin resistance and risk of congestive heart failure.

Authors:  Erik Ingelsson; Johan Sundström; Johan Arnlöv; Björn Zethelius; Lars Lind
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

9.  Regulation of energy metabolism of the heart during acute increase in heart work.

Authors:  G W Goodwin; C S Taylor; H Taegtmeyer
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

Review 10.  Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

Authors:  M Prentki; B E Corkey
Journal:  Diabetes       Date:  1996-03       Impact factor: 9.461

View more
  39 in total

1.  A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.

Authors:  Cheng-Yang Wu; Santhosh Satapati; Wenjun Gui; R Max Wynn; Gaurav Sharma; Mingliang Lou; Xiangbing Qi; Shawn C Burgess; Craig Malloy; Chalermchai Khemtong; A Dean Sherry; David T Chuang; Matthew E Merritt
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 2.  Exercise Intolerance In Heart Failure With Preserved Ejection Fraction.

Authors:  Anisha A Gupte; Dale J Hamilton
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Apr-Jun

3.  Remodeling of substrate consumption in the murine sTAC model of heart failure.

Authors:  Aslan Turer; Francisco Altamirano; Gabriele G Schiattarella; Herman May; Thomas G Gillette; Craig R Malloy; Matthew E Merritt
Journal:  J Mol Cell Cardiol       Date:  2019-07-21       Impact factor: 5.000

4.  Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.

Authors:  Qingtong Wang; Yongming Liu; Qin Fu; Bing Xu; Yuan Zhang; Sungjin Kim; Ruensern Tan; Federica Barbagallo; Toni West; Ethan Anderson; Wei Wei; E Dale Abel; Yang K Xiang
Journal:  Circulation       Date:  2016-11-04       Impact factor: 29.690

5.  Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice.

Authors:  Dharendra Thapa; Bingxian Xie; Manling Zhang; Michael W Stoner; Janet R Manning; Brydie R Huckestein; Lia R Edmunds; Steven J Mullett; Charles F McTiernan; Stacy G Wendell; Michael J Jurczak; Iain Scott
Journal:  J Mol Cell Cardiol       Date:  2019-02-26       Impact factor: 5.000

Review 6.  Pathomechanisms in heart failure: the contractile connection.

Authors:  G J M Stienen
Journal:  J Muscle Res Cell Motil       Date:  2014-11-07       Impact factor: 2.698

7.  Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.

Authors:  Carlos E Mendez; Rebekah J Walker; Christian R Eiler; Basem M Mishriky; Leonard E Egede
Journal:  Postgrad Med       Date:  2019-07-23       Impact factor: 3.840

Review 8.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

9.  Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension.

Authors:  Yasmin S Hamirani; Bijoy K Kundu; Min Zhong; Andrew McBride; Yinlin Li; Giovanni E Davogustto; Heinrich Taegtmeyer; Jamieson M Bourque
Journal:  Cardiology       Date:  2015-11-24       Impact factor: 1.869

10.  Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Authors:  Heinrich Taegtmeyer; Anja Karlstaedt
Journal:  Circulation       Date:  2018-02-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.